A carregar...
Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
With increasing therapeutic options available for advanced hepatocellular carcinoma (HCC), the timing and sequencing of locoregional and systemic therapy need to be re-examined. This is especially so for patients with intermediate HCC, so as to optimize responses while preserving liver reserves, and...
Na minha lista:
| Publicado no: | ESMO Open |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8086015/ https://ncbi.nlm.nih.gov/pubmed/33887687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.esmoop.2021.100129 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|